Development Level

Tchem 9 | 1,598
Tbio 1 | 11,445

IMPC Phenotype

abnormal lens morphology 1 | 81
embryonic lethality prior to t... 1 | 278
increased erythrocyte cell num... 1 | 39
increased hematocrit 1 | 46
preweaning lethality, complete... 1 | 979

Disease

Carcinoma 8 | 11,493
atypical teratoid / rhabdoid tumor 8 | 5,112
glioblastoma 7 | 5,792
Cancer 6 | 2,499
adult high grade glioma 6 | 3,801
medulloblastoma, large-cell 5 | 6,241
osteosarcoma 5 | 7,950
ovarian cancer 5 | 8,520
psoriasis 5 | 6,694
Astrocytoma, Pilocytic 4 | 3,081
group 3 medulloblastoma 4 | 4,104
lung cancer 4 | 4,740
Cholestasis, Extrahepatic 3 | 25
Vascular disease 3 | 319
ependymoma 3 | 4,679
group 4 medulloblastoma 3 | 1,855
subependymal giant cell astrocytoma 3 | 2,287
Alzheimer's disease 2 | 658
Arthritis 2 | 290
Brain disease 2 | 96
Cardiomyopathies 2 | 110
Cholestasis 2 | 155
Disease Models, Animal 2 | 155
Hyperalgesia 2 | 83
Lung disease 2 | 142
Parkinson's disease 2 | 392
Precancerous Conditions 2 | 80
Reperfusion Injury 2 | 86
Schizophrenia 2 | 1,160
Trigeminal Neuralgia 2 | 24
diabetes mellitus 2 | 1,728
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
invasive ductal carcinoma 2 | 2,951
juvenile dermatomyositis 2 | 1,187
lung adenocarcinoma 2 | 2,716
posterior fossa group A ependymoma 2 | 468
primitive neuroectodermal tumor 2 | 3,035
tuberculosis 2 | 2,010
Abnormality of the metaphyses 1 | 48
Abnormally-shaped vertebrae 1 | 31
Advanced bone age 1 | 35
Agenesis of teeth 1 | 21
Autism Spectrum Disorders 1 | 75
Autistic behavior 1 | 20
Blastic phase chronic myeloid leukemia 1 | 58
Cell Transformation, Neoplastic 1 | 97
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Chronic phase chronic myeloid leukemia 1 | 45
Colonic Neoplasms 1 | 142
Conductive hearing loss 1 | 123
Congenital sensorineural hearing loss 1 | 12
Dental abnormalities 1 | 60
Disorder of eye 1 | 27
Downward slant of palpebral fissure 1 | 158
Edema 1 | 81
Encephalopathies 1 | 43
Eye Abnormalities 1 | 35
Fatty liver disease 1 | 103
Flexion contracture of proximal interphalangeal joint 1 | 75
Freckles 1 | 33
Gaucher disease type 1 1 | 180
Hamman-Rich syndrome 1 | 34
Hyperactive behavior 1 | 91
Hyperglycemia 1 | 137
Hyperplasia of supraorbital margins 1 | 19
Hyperplasia of supraorbital ridge 1 | 19
Hypersensitivity 1 | 63
Hypertrophy of supraorbital margins 1 | 19
Hypertrophy of supraorbital ridge 1 | 19
Hypoplasia of muscle 1 | 5
Ischemia 1 | 28
Joint stiffness 1 | 84
Lennox-Gastaut syndrome 1 | 34
Liver Failure, Acute 1 | 29
Liver disease 1 | 237
Marijuana Abuse 1 | 31
Mental deterioration 1 | 32
Mitral regurgitation, mild 1 | 32
Mitral valve insufficiency 1 | 49
Myocardial Reperfusion Injury 1 | 37
Myoclonus 1 | 74
Neoplasm Metastasis 1 | 168
Neoplasms 1 | 63
Neoplastic Cell Transformation 1 | 89
Neurodegenerative disease 1 | 414
Osteoporosis 1 | 363
Patellar tendinitis 1 | 2
Periodontal disease 1 | 40
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 1 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 1 | 47
Prominent supraorbital ridges 1 | 19
Reduced number of teeth 1 | 21
Sensorineural Hearing Loss (disorder) 1 | 284
Short thumb terminal phalanx 1 | 5
Tonic - clonic seizures 1 | 44
Tooth Abnormalities 1 | 69
Toxic encephalopathy 1 | 141
axial spondyloarthropathy 1 | 28
inflammatory breast cancer 1 | 286

Tissue

Blood and immune system 10 | 16,909
Cardiovascular System 10 | 15,192
Digestive Tract 10 | 17,369
Endocrine System 10 | 18,159
Female tissues 10 | 17,400
Liver and Pancreas 10 | 16,750
Male tissues 10 | 17,142
Nervous System 10 | 16,725
Respiratory system 10 | 16,393
Skin and soft tissues 10 | 17,230
Urinary Tract 10 | 16,678

Target Family

Kinase 9 | 634
Transcription Factor 1 | 1,400

PathwayCommons: inoh Pathway

http://pathwaycommons.org/pc2/... 10 | 10
http://pathwaycommons.org/pc2/... 236 | 236
http://pathwaycommons.org/pc2/... 235 | 235
http://pathwaycommons.org/pc2/... 233 | 233
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 183 | 183
http://pathwaycommons.org/pc2/... 178 | 178
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 123 | 123
http://pathwaycommons.org/pc2/... 96 | 96
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 34 | 34
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 28 | 28
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 22 | 22
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Mitogen-activated protein kinase 10 MAPK10 Tchem Kinase -2.29568 193.3 384
Mitogen-activated protein kinase 12 MAPK12 Tchem Kinase -1.95173 88.4 378
Cyclic AMP-dependent transcription factor ATF-2 ATF2 Tbio Transcription Factor -2.23104 170.7 1819
Dual specificity mitogen-activated protein kinase kinase 6 MAP2K6 Tchem Kinase -2.01763 74.4 636
Mitogen-activated protein kinase kinase kinase 7 MAP3K7 Tchem Kinase -1.46817 32.4 765
Mitogen-activated protein kinase 13 MAPK13 Tchem Kinase -2.63128 394.0 648
Mitogen-activated protein kinase 14 MAPK14 Tchem Kinase -3.36007 2240.8 1574
Mitogen-activated protein kinase 8 MAPK8 Tchem Kinase -3.81256 5770.8 1150
Mitogen-activated protein kinase 9 MAPK9 Tchem Kinase -2.67320 359.2 611
Mitogen-activated protein kinase 11 MAPK11 Tchem Kinase -2.06160 98.6 336